AzTrials
AzTrials

Intrauterine Growth Restriction (IUGR)NCT07031583

Intrauterine Growth Restriction and Intrauterine Fetal Death

A study testing Delayed Umbilical Cord Clamping (DCC) and Early Umbilical Cord Clamping (ECC) in people with Intrauterine Growth Restriction (IUGR) and Oxidative Stress in Neonates, run by Istanbul Arel University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigated whether delaying the clamping of the umbilical cord after birth can reduce harmful oxidative stress in newborns, especially in those who did not grow well during pregnancy (intrauterine growth restriction - IUGR). Read more about this study

Who is it for?
Ages 0 hours to 1 hourHealthy volunteers can take part
What is being tested?
Delayed Umbilical Cord Clamping (DCC) and Early Umbilical Cord Clamping (ECC)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
11 Mar 2025to 2 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 hours to 1 hour
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Neonates born at ≥29 weeks of gestation
  • Diagnosed with Intrauterine Growth Restriction (IUGR) or classified as Appropriate for Gestational Age (AGA) based on prenatal ultrasonography
  • For IUGR group: estimated fetal weight below the 10th percentile and abnormal umbilical artery Doppler findings (e.g., elevated resistance index, absent or reversed end-diastolic flow)
  • Neonates delivered at Kayseri City Hospital
  • Informed consent obtained from parents or legal guardians

Who cannot join

  • Major congenital anomalies or structural malformations
  • Intrauterine infections
  • Preterm birth before 29 weeks of gestation
  • Fetal hydrops
  • Maternal conditions such as preeclampsia, gestational diabetes, or systemic disease
  • Emergency cesarean delivery
  • Neonates requiring immediate postnatal intubation or invasive resuscitation
  • Signs of severe perinatal distress preventing umbilical cord sampling

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Kayseri City Hospital

    Kayseri, Kayseri, 38130

Other trials in Turkey (Türkiye)

About this study

Official title: Impact of Early Versus Delayed Cord Clamping on Oxidative Stress in Neonates With Intrauterine Growth Restriction: A Prospective Comparative Study

This study investigated whether delaying the clamping of the umbilical cord after birth can reduce harmful oxidative stress in newborns, especially in those who did not grow well during pregnancy (intrauterine growth restriction - IUGR). By comparing early and delayed cord clamping in 90 newborns, researchers found that delayed clamping improved antioxidant protection and reduced signs of oxidative damage. These benefits were more significant in babies with IUGR. The results suggest that delaying cord clamping could help support better early health outcomes in vulnerable newborns.

Read the detailed description

This prospective, randomized clinical study examined the effects of early versus delayed umbilical cord clamping on oxidative stress in newborns, with a specific focus on those diagnosed with intrauterine growth restriction (IUGR). Oxidative stress occurs when the body has an imbalance between harmful molecules (oxidants) and protective defenses (antioxidants), which may negatively affect newborns, especially those who experienced limited growth in the womb.

A total of 90 newborns were included and grouped based on their growth status (IUGR or appropriate for gestational age) and the timing of cord clamping (early: within 60 seconds; delayed: after 60-180 seconds). Blood samples were taken from the umbilical cord immediately after birth to measure markers of oxidative stress and antioxidant activity.

The study found that delayed cord clamping was associated with improved antioxidant levels and reduced oxidative stress, particularly in growth-restricted infants. These findings suggest that delaying cord clamping may provide protective health benefits for high-risk newborns.

Being tested
Delayed Umbilical Cord Clamping (DCC), Early Umbilical Cord Clamping (ECC)
Keywords
Umbilical Cord Clamping, Fetal Growth Restriction, Oxidative Stress, Total Antioxidant Capacity, Total Oxidant Status
Medical subject headings
Fetal Growth Retardation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delayed Umbilical Cord Clamping (DCC)Procedure or surgery

    The umbilical cord was clamped between 60 and 180 seconds after birth or after the cessation of cord pulsation, in accordance with WHO recommendations. This procedure allows for additional placental transfusion and potential enhancement of neonatal antioxidant capacity.

  • Early Umbilical Cord Clamping (ECC)Procedure or surgery

    The umbilical cord was clamped within the first 60 seconds after birth. This represents the standard or traditional approach used for comparison with delayed clamping in terms of oxidative stress outcomes.

Study groups in NCT07031583
Study groupRoleWhat they receive
IUGR-Delayed Cord Clamping (IUGR-DCC)ExperimentalNeonates diagnosed with intrauterine growth restriction (IUGR) received delayed umbilical cord clamping, performed 60-180 seconds after birth. Umbilical cord blood samples were collected immediately for oxidative stress analysis.
Receives: Procedure: Delayed Umbilical Cord Clamping (DCC)
IUGR - Early Cord Clamping (IUGR-ECC)Active comparatorNeonates with IUGR underwent early umbilical cord clamping, within 60 seconds after birth. Umbilical cord blood samples were collected for comparison with delayed clamping groups.
Receives: Procedure: Early Umbilical Cord Clamping (ECC)
AGA - Delayed Cord Clamping (AGA-DCC)ExperimentalNeonates appropriate for gestational age (AGA) underwent delayed cord clamping, performed 60-180 seconds after birth. Biochemical markers of oxidative stress were measured using cord blood samples.
Receives: Procedure: Delayed Umbilical Cord Clamping (DCC)
AGA - Early Cord Clamping (AGA-ECC)Active comparatorAGA neonates received early umbilical cord clamping, within the first 60 seconds post-delivery. Cord blood was analyzed for oxidative stress markers as a baseline comparator.
Receives: Procedure: Early Umbilical Cord Clamping (ECC)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total Antioxidant Status (TAS)

    TAS levels in umbilical cord blood will be measured using a validated colorimetric method (Erel, 2004). Higher values indicate greater antioxidant capacity.

    Measured: At birth (within 30 minutes postpartum)

  2. Total Oxidant Status (TOS)

    TOS levels in umbilical cord blood will be assessed using a spectrophotometric assay (Erel, 2005). Elevated levels reflect greater oxidative stress.

    Measured: At birth (within 30 minutes postpartum)

  3. Oxidative Stress Index (OSI)

    OSI will be calculated as the ratio of TOS to TAS multiplied by 10. It provides a combined indicator of oxidative balance.

    Measured: At birth (within 30 minutes postpartum)

Secondary outcomes (3)
  1. Catalase Enzyme Activity

    Catalase activity in umbilical cord blood will be measured via spectrophotometry. Catalase is an endogenous antioxidant enzyme that reflects neonatal oxidative defense capacity.

    Measured: At birth (within 30 minutes postpartum)

  2. 1-Minute and 5-Minute APGAR Scores

    Clinical scoring system evaluating neonatal adaptation at 1 and 5 minutes of life (heart rate, respiration, muscle tone, reflex, color). Higher scores indicate better clinical condition.

    Measured: Within 5 minutes after birth

  3. Birth Weight

    Neonatal birth weight (in grams) will be recorded and compared across groups to evaluate any association with clamping time and oxidative status.

    Measured: At birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2025
  2. Study start11 Mar 2025
  3. Primary completion1 Jun 2025
  4. Study completion2 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
Four-group parallel design based on neonatal growth status and cord clamping timing.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07031583
Sponsor's protocol ID
KayseriCityHospital
Status last verified
Jun 2025
First submitted
13 Jun 2025
Last updated
22 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Abdel Ghany EA, Alsharany W, Ali AA, Youness ER, Hussein JS. Anti-oxidant profiles and markers of oxidative stress in preterm neonates. Paediatr Int Child Health. 2016 May;36(2):134-40. doi: 10.1179/2046905515Y.0000000017.

    PubMed 25940692
  • Demir MB, Copuroglu M, Ozdemir A, Kocer D. Impact of early versus delayed cord clamping on oxidative stress in neonates with intrauterine growth restriction: a prospective randomized controlled trial. BMC Pregnancy Childbirth. 2025 Dec 5;25(1):1291. doi: 10.1186/s12884-025-08335-z.

    PubMed 41350641

Questions about this trial

What is this clinical trial studying?

A study testing Delayed Umbilical Cord Clamping (DCC) and Early Umbilical Cord Clamping (ECC) in people with Intrauterine Growth Restriction (IUGR) and Oxidative Stress in Neonates, run by Istanbul Arel University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Antioxidant Status (TAS) (time frame: At birth (within 30 minutes postpartum)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07031583, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in